Case Report: Development of Miliary Pulmonary Tuberculosis in a Patient with Peritoneal Tuberculosis after COVID-19 Upper Respiratory Tract Infection

View More View Less
  • 1 Department of Family Medicine, Hamad Medical Corporation, Doha, Qatar;
  • 2 Department of Bariatric Medicine, Hamad Medical Corporation, Doha, Qatar;
  • 3 Department of Gastroenterology, Hamad Medical Corporation, Doha, Qatar;
  • 4 Department of Infectious Disease, Hamad Medical Corporation, Doha, Qatar

We report a 29-year-old patient who presented with coronavirus disease 2019 (COVID-19) upper respiratory tract infection in addition to clinical, laboratory, and radiological findings highly suggestive of peritoneal tuberculosis (TB) without pulmonary involvement. Two weeks after the resolution of COVID-19 infection, he presented with shortness of breath and oxygen desaturation requiring intubation and admission to the intensive care unit. The workup confirmed miliary pulmonary TB. The patient subsequently improved on antitubercular treatment. We discuss the possible contribution of COVID-19 infection to the rapid progression of TB infection to involve the lung in a miliary pattern, and how the coexistence of the two diseases might have led to a worse outcome.

Author Notes

Address correspondence to Moustafa M. Elziny, Department of Family Medicine, Hamad Medical Corporation, PO Box 3050, Doha, Qatar. E-mail: drmostafaelzeiny@gmail.com

Disclosure: We have read and complied with the policy of the journal on ethical consent, as stated in the guide to authors. The institutional review board has approved the work (manuscript no. MRC-04-20-684).

Authors’ addresses: Moustafa M. Elziny, Department of Family Medicine, Hamad Medical Corporation, Doha, Qatar, E-mail: drmostafaelzeiny@gmail.com. Ahmed Ghazy, Department of Bariatric Medicine, Hamad Medical Corporation, Doha, Qatar, E-mail: dr.ahmedazmyghazy@gmail.com. Khaled A. Elfert, Department of Gastroenterology, Hamad Medical Corporation, Doha, Qatar, E-mail: kh.elfert90@gmail.com. Mohamed Aboukamar, Department of Infectious Disease, Hamad Medical Corporation, Doha, Qatar, E-mail: mkamar@hamad.qa.

Save